Skip to main content
Log in

Serum levels of fetuin A are increased in women with gestational diabetes mellitus

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Fetuin A is associated with insulin resistance and type 2 diabetes mellitus (DM). We aimed to investigate circulating fetuin A concentrations in gestational diabetes mellitus (GDM).

Methods

Serum fetuin A levels were studied in 26 pregnant women with GDM and 24 healthy pregnant women between 24th and 28th gestational weeks. Fetuin A levels were also evaluated in 18 of women with GDM at postpartum.

Results

Fetuin A concentrations were significantly increased in women with GDM compared to healthy pregnant women (35.0 ± 3.2 vs. 32.0 ± 4.4 ng/ml; p = 0.01). Also, fetuin A levels in women with GDM significantly decreased at postpartum period (35.0 ± 3.2 vs. 31.7 ± 3.9 ng/ml; p = 0.001). In whole pregnant women, there were positive correlations between fetuin A and HbA1c (r = 0.418, p = 0.002), total cholesterol (r = 0.332, p = 0.018) and triglycerides (r = 0.306, p = 0.031). Multivariate regression analysis demonstrated that HbA1c was the important predictor of circulating fetuin A level (beta = 0.375, p = 0.01).

Conclusion

In conclusion, our results indicate that serum fetuin A concentrations are increased in women with GDM and decreased after delivery. Therefore, fetuin A might have a role in the development of insulin resistance and the metabolic changes in GDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arnaud P, Miribel L, Emerson DL (1988) Alpha 2-HS glycoprotein. Methods Enzymol 163:431–441

    Article  CAS  PubMed  Google Scholar 

  2. Mori K, Emoto M, Inaba M (2011) Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov 5(2):124–146

    Article  CAS  PubMed  Google Scholar 

  3. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4):853–857

    Article  CAS  PubMed  Google Scholar 

  4. Enli Y, Fenkci SM, Fenkci V, Oztekin O (2013) Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 29(12):1036–1039. doi:10.3109/09513590.2013.829442

    Article  CAS  PubMed  Google Scholar 

  5. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol 75(4):450–455. doi:10.1111/j.1365-2265.2011.04070.x

    Article  CAS  Google Scholar 

  6. Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N (2012) Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol 64(12):1703–1708. doi:10.1111/j.2042-7158.2012.01561.x

    Article  PubMed  Google Scholar 

  7. Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G (2011) Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One 6(4):e19228. doi:10.1371/journal.pone.0019228

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the US. Diabetes 62(1):49–55. doi:10.2337/db12-0372

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164(1–2):87–98

    Article  CAS  PubMed  Google Scholar 

  10. Catalano PM (2014) Trying to understand gestational diabetes. Diabet Med 31(3):273–281. doi:10.1111/dme.12381

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Paakkonen M, Kuulasmaa T, Heinonen S, Laakso M (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169(3):291–297. doi:10.1530/EJE-13-0286

    Article  CAS  PubMed  Google Scholar 

  12. Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868

    Article  PubMed  Google Scholar 

  13. Barbour LA, McCurdy CE, Hernandez TL, Friedman JE (2011) Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Meta 96(5):1431–1441. doi:10.1210/jc.2010-2116

    Article  CAS  Google Scholar 

  14. Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I, Winkler G (2002) Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol 147(2):243–248

    Article  CAS  PubMed  Google Scholar 

  15. Farhan S, Handisurya A, Todoric J, Tura A, Pacini G, Wagner O, Klein K, Jarai R, Huber K, Kautzky-Willer A (2012) Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol 2012:896736. doi:10.1155/2012/896736

    Article  PubMed Central  PubMed  Google Scholar 

  16. Coustan DR, Carpenter MW (1998) The diagnosis of gestational diabetes. Diabetes Care 21(Suppl 2):B5–B8

    PubMed  Google Scholar 

  17. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502

    CAS  PubMed  Google Scholar 

  18. Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 376(Pt 1):135–145. doi:10.1042/BJ20030676

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier JP (2000) Fetuin-B, a second member of the fetuin family in mammals. Biochem J 350(Pt 2):589–597

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Briana DD, Boutsikou M, Gourgiotis D, Boutsikou T, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A (2008) Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med 21(11):826–830. doi:10.1080/14767050802326255

    Article  CAS  PubMed  Google Scholar 

  21. Gunduz FO, Yildirmak ST, Temizel M, Faki Y, Cakmak M, Durmuscan M, Sezgin F (2011) Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus. Diabetes Metab J 35(5):523–528. doi:10.4093/dmj.2011.35.5.523

    Article  PubMed Central  PubMed  Google Scholar 

  22. Erdmann J, Salmhofer H, Knauss A, Mayr M, Wagenpfeil S, Sypchenko O, Luppa P, Schusdziarra V (2012) Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus. Regul Pept 178(1–3):6–10. doi:10.1016/j.regpep.2012.02.004

    Article  CAS  PubMed  Google Scholar 

  23. Liu Y, Xu M, Xu Y, Li M, Wang T, Chen Y, Bi Y (2012) Positive correlation between chronic hyperglycemia and serum fetuin-A levels in middle-aged and elderly Chinese. J Diabetes 4(4):351–358. doi:10.1111/1753-0407.12000

    Article  PubMed  Google Scholar 

  24. Ozyazgan S, Karaoglu K, Kurt A, Altinok A, Konukoglu D, Osar Siva Z, Andican G (2013) Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients. Minerva Med 104(3):287–293

    CAS  PubMed  Google Scholar 

  25. Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO (2013) Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 10(5):459–467. doi:10.1177/1479164113490766

    Article  PubMed  Google Scholar 

  26. Stefan N, Haring HU (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19(4):394–395. doi:10.1038/nm.3116

    Article  CAS  PubMed  Google Scholar 

  27. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18(8):1279–1285. doi:10.1038/nm.2851

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully thank Elif Ayvali for helping in laboratory analysis.

Conflict of interest

There is no conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ozlem Turhan Iyidir.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iyidir, O.T., Degertekin, C.K., Yilmaz, B.A. et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Arch Gynecol Obstet 291, 933–937 (2015). https://doi.org/10.1007/s00404-014-3490-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3490-3

Keywords

Navigation